USLM vs DYN
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
USLM · United States Lime & Minerals$118.10 ▼ 1.10%
DYN · Dyne Therapeutics$18.07 ▲ 4.09%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- USLM -0.8%
- DYN -2.4%
Head to head
| Metric | USLM | DYN |
|---|---|---|
| Price | $118.10 | $18.07 |
| Change today | ▼ 1.10% | ▲ 4.09% |
| Market cap | $3.39B | $3.39B |
| Return, 3 months | -1.8% | -31.8% |
| Return, year to date | -1.2% | -7.6% |
| Return, 1 year | +2.3% | -1.6% |
| P/E (TTM) | 25.5 | – |
| P/B | 4.6 | 3.6 |
| P/E percentile vs own 5y | 60th | 33rd |
| Dividend yield | 0.20% | – |
| Revenue growth (YoY, latest qtr) | +8.3% | – |
| Net profit growth (YoY) | +11.9% | -61.1% |
| Gross margin | 48.5% | – |
| Operating margin | 42.1% | – |
| Net margin | 35.7% | – |
| Return on equity | 21.4% | -81.6% |
| Analyst target vs. price | – | +90.9% |
| Analyst buy share | – | 90% |
| RSI (14) | 59 | 57 |
| 30-day volatility | 33.1% | 57.9% |
| Max drawdown, 1 year | -30.1% | -46.8% |
| Trend read | Strong uptrend | Leaning bullish |
| Analyst consensus | – | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- USLM is the largest of the group by market value.
- USLM has returned the most over the past year.
- USLM has been the calmest stock over the last 30 days.